ISinopharm BBIBP-CorV COVID-19 ngumuthi wokugoma ongasebenzi owenziwe ngezinhlayiya zegciwane ezikhuliswe ngamasiko ezingenawo amandla we-pathogenic. Lo mqokelwa ukugoma wasungulwa yiSinopharm Holdings neBeijing Institute of Biological Products.